| Summary of Restatement of Warrants in Financial Statements |
The following summarizes the effect of the Restatement on each financial statement line item for each period presented herein. The restatement had no impact on net cash flows from operating, investing or financing activities.
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Balance Sheet as of October 26, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
7,912,000 |
|
|
|
7,912,000 |
|
Ordinary shares subject to possible redemption |
|
|
238,575,390 |
|
|
|
(7,912,000 |
) |
|
|
230,663,390 |
|
|
|
|
194 |
|
|
|
79 |
|
|
|
273 |
|
Additional paid-in capital |
|
|
5,049,620 |
|
|
|
444,588 |
|
|
|
5,494,208 |
|
|
|
|
(50,529 |
) |
|
|
(444,667 |
) |
|
|
(495,196 |
) |
Pro Forma Balance Sheet as of October 26, 2020 (unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
9,713,800 |
|
|
|
9,713,800 |
|
Ordinary shares subject to possible redemption |
|
|
247,423,470 |
|
|
|
(9,713,800 |
) |
|
|
237,709,670 |
|
|
|
|
200 |
|
|
|
97 |
|
|
|
297 |
|
Additional paid-in capital |
|
|
5,049,620 |
|
|
|
1,908,173 |
|
|
|
6,957,793 |
|
|
|
|
(50,529 |
) |
|
|
(1,908,270 |
) |
|
|
(1,958,799 |
) |
Balance Sheet as of December 31, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
12,030,850 |
|
|
|
12,030,850 |
|
Ordinary shares subject to possible redemption |
|
|
246,805,330 |
|
|
|
(12,030,850 |
) |
|
|
234,774,480 |
|
|
|
|
206 |
|
|
|
120 |
|
|
|
326 |
|
Additional paid-in capital |
|
|
5,667,824 |
|
|
|
4,225,201 |
|
|
|
9,893,025 |
|
|
|
|
(668,674 |
) |
|
|
(4,225,321 |
) |
|
|
(4,893,995 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
Period from September 8, 2020 (inception) to December 31, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
Income (Loss) from change in FV of warrants |
|
|
— |
|
|
|
(3,779,050 |
) |
|
|
(3,779,050 |
) |
Offering costs attributable to warrants |
|
|
— |
|
|
|
(446,271 |
) |
|
|
(446,271 |
) |
|
|
|
(668,674 |
) |
|
|
(4,225,321 |
) |
|
|
(4,893,995 |
) |
Basic and diluted net loss per ordinary share, Class B ordinary shares |
|
|
(0.11 |
) |
|
|
(0.66 |
) |
|
|
(0.77 |
) |
Cash Flow Statement for the period from September 8, 2020 (inception) to December 31, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(668,674 |
) |
|
|
(4,225,321 |
) |
|
|
(4,893,995 |
) |
Offering costs attributable to warrants |
|
|
— |
|
|
|
446,271 |
|
|
|
446,271 |
|
Change in fair value of warrant liability |
|
|
— |
|
|
|
3,779,050 |
|
|
|
3,779,050 |
|
Initial classification of warrant liability |
|
|
— |
|
|
|
7,912,000 |
|
|
|
7,912,000 |
|
Initial value of Class A ordinary shares subject to possible redemption |
|
|
238,575,390 |
|
|
|
(7,912,000 |
) |
|
|
230,663,390 |
|
Change in value of Class A ordinary shares to possible redemption |
|
|
8,229,940 |
|
|
|
(4,118,850 |
) |
|
|
4,111,090 |
|
|
The following summarizes the effect of the Restatement on each financial statement line item for each period presented herein
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Sheet as of December 31, 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
12,030,850 |
|
|
|
12,030,850 |
|
Ordinary shares subject to possible redemption |
|
|
246,805,330 |
|
|
|
12,030,850 |
|
|
|
234,774,480 |
|
|
|
|
206 |
|
|
|
120 |
|
|
|
326 |
|
Additional paid-in capital |
|
|
5,667,824 |
|
|
|
4,225,201 |
|
|
|
9,893,025 |
|
|
|
|
(668,674 |
) |
|
|
(4,225,321 |
) |
|
|
(4,893,995 |
) |
|